The expression of SPARC was negatively correlated with differentiation, Lauren classification, lymph node metastasis, and clinical stage, while lymph node metastasis was an independent prognostic factor for patients with gastric cancer [47–49]. This evidence concerns the gene SPARC and metastatic malignant neoplasm in the lymph nodes.